| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/24/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 10/18/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 10/14/2022 |
SC 13D/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in FORMA THERAPEUTICS HOLDING, INC. |
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 10/14/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/14/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/14/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 10/14/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 10/07/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/07/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/28/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/28/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/15/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 09/15/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 09/02/2022 |
SC 13D/A
| RA CAPITAL MANAGEMENT, L.P. reports a 18.9% stake in FORMA THERAPEUTICS HOLDING, INC. |
| 09/01/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 09/01/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 09/01/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 09/01/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Agreement and Plan of Merger, by and among Novo Nordisk A/S, NNUS New Dev, Inc. and Forma Therapeutics Holdings, Inc",
"Tender and Support Agreement, by and among Novo Nordisk A/S, NNUS New Dev, Inc. and certain Stockholders of Forma Therapeutics Holdings, Inc",
"Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders Bagsværd, Denmark and Watertown, Mass, US September 1, 2022" |
|
| 08/05/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/05/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/05/2022 |
8-K
| Quarterly results |
| 07/25/2022 |
8-K
| Quarterly results |
| 06/09/2022 |
8-K
| Quarterly results |
| 06/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/26/2022 |
8-K
| Quarterly results |
| 05/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/06/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/06/2022 |
8-K
| Quarterly results |
|